Last reviewed · How we verify
Comparing Patient Satisfaction Throughout the Day With PATADAY (OLOPATADINE HYDROCHLORIDE) 0.2% QD or BEPREVE (BEPOTASTINE BESILATE OPHTHALMIC SOLUTION) 1.5% BID
The purpose of this study is to compare patient satisfaction with Pataday (Olopatadine hydrochloride 0.2%) one daily (QD) and Bepreve (Bepotastine besilate ophthalmic solution 1.5%) two times a day (BID).
Details
| Lead sponsor | McCabe Vision Center |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 30 |
| Start date | 2011-09 |
| Completion | 2011-12 |
Conditions
- Eye Allergies
Interventions
- Olopatadine hydrochloride 0.2%
- Bepotastine besilate ophthalmic solution 1.5%
Primary outcomes
- Relief of ocular itching — 5 weeks
All day relief of ocular itching throughout the treatment period.
Countries
United States